You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 39 No. 8, August 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Visual Loss in Pseudotumor Cerebri

Follow-up of 57 Patients From Five to 41 Years and a Profile of 14 Patients With Permanent Severe Visual Loss

James J. Corbett, MD; Peter J. Savino, MD; H. Stanley Thompson, MD; Tulay Kansu, MD; Norman J. Schatz, MD; Linda S. Orr, MD; Daniel Hopson, MD

Arch Neurol. 1982;39(8):461-474.


Abstract

• The prognosis for vision in most patients with pseudotumor cerebri is excellent; however, visual loss, which is the only serious complication, may occur either early or late in the course of the disease. A group of 57 patients was followed up five to 41 years with visual fields, visual acuity, and fundus photographs. Blinding visual loss or severe visual impairment in one or both eyes occurred in 14 patients, and in seven patients, this occurred months to years after the initial symptoms. Systemic hypertension was a significant risk factor for visual loss in patients with pseudotumor cerebri, and blindness occurred in eight of 13 patients who were hypertensive. Despite suggestions that blind spot measurement is useful for following up patients with this condition, we believe that sequential quantitative perimetry gives more complete information and is essential to rational decision making in the treatment of pseudotumor cerebri.



Author Affiliations

From the Neuroophthalmology Unit, Wills Eye Hospital, Philadelphia (Drs Corbett, Savino, Kansu, Schatz, and Orr), and the Neuroophthalmology Unit, University of Iowa, Iowa City (Drs Corbett, Thompson, and Hopson).


Footnotes

Accepted for publication Sept 13, 1981.

Reprint requests to Department of Neurology, University of Iowa Hospitals, Iowa City, IA 52242 (Dr Corbett).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Behavioral Disorders in Children With Idiopathic Intracranial Hypertension
Parness-Yossifon et al.
J Child Neurol 2008;23:447-450.
ABSTRACT  

Racial differences in idiopathic intracranial hypertension
Bruce et al.
Neurology 2008;70:861-867.
ABSTRACT | FULL TEXT  

Long-term follow-up of idiopathic intracranial hypertension: The Iowa experience
Shah et al.
Neurology 2008;70:634-640.
ABSTRACT | FULL TEXT  

Drugs used in childhood idiopathic or benign intracranial hypertension
Matthews
EDUCATION AND PRACTICE 2008;93:19-25.
FULL TEXT  

Idiopathic intracranial hypertension and visual function
Acheson
Br Med Bull 2007;0:ldl019v1-12.
ABSTRACT | FULL TEXT  

Fulminant idiopathic intracranial hypertension
Thambisetty et al.
Neurology 2007;68:229-232.
ABSTRACT | FULL TEXT  

Idiopathic intracranial hypertension: Risk of recurrences
Kesler et al.
Neurology 2004;63:1737-1739.
ABSTRACT | FULL TEXT  

Psychiatric Aspects of Child and Adolescent Obesity: A Review of the Past 10 Years
Zametkin et al.
Focus 2004;2:625-641.
ABSTRACT | FULL TEXT  

Pseudotumor Cerebri in Children With Sickle Cell Disease: A Case Series
Henry et al.
Pediatrics 2004;113:e265-269.
ABSTRACT | FULL TEXT  

Diffuse brain oedema in idiopathic intracranial hypertension: a quantitative magnetic resonance imaging study
Bastin et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:1693-1696.
ABSTRACT | FULL TEXT  

Not so benign intracranial hypertension
Digre
BMJ 2003;326:613-614.
FULL TEXT  

Lesson of the week: Doxycycline induced intracranial hypertension
Lochhead and Elston
BMJ 2003;326:641-642.
FULL TEXT  

Optical Coherence Tomography Demonstrates Subretinal Macular Edema From Papilledema
Hoye III et al.
Arch Ophthalmol 2001;119:1287-1290.
ABSTRACT | FULL TEXT  

Idiopathic intracranial hypertension: any light on the mechanism of the raised pressure?
WALKER
J. Neurol. Neurosurg. Psychiatry 2001;71:1-5.
FULL TEXT  

Divergence Insufficiency Revisited: Natural History of Idiopathic Cases and Neurologic Associations
Jacobson
Arch Ophthalmol 2000;118:1237-1241.
ABSTRACT | FULL TEXT  

Idiopathic intracranial hypertension: Relationship to depression, anxiety, and quality of life
Kleinschmidt et al.
Neurology 2000;54:319-319.
ABSTRACT | FULL TEXT  

Visual Outcome in a Prospective Study of Idiopathic Intracranial Hypertension
Rowe and Sarkies
Arch Ophthalmol 1999;117:1571-1572.
FULL TEXT  

Use of scanning laser ophthalmoscopy to monitor papilloedema in idiopathic intracranial hypertension
Mulholland et al.
Br. J. Ophthalmol. 1998;82:1301-1305.
ABSTRACT | FULL TEXT  

Diagnosis and management of benign intracranial hypertension
Soler et al.
Arch. Dis. Child. 1998;78:89-94.
FULL TEXT  

Idiopathic Intracranial Hypertension in Children: The Iowa Experience
Babikian et al.
J Child Neurol 1994;9:144-149.
ABSTRACT  

Controversies in Diagnosis and Management of Pseudotumor Cerebri
Carlow et al.
Arch Neurol 1987;44:128-129.
ABSTRACT  

Visual Loss in Pseudotumor Cerebri: Incidence and Defects Related to Visual Field Strategy
Wall and George
Arch Neurol 1987;44:170-175.
ABSTRACT  

Pseudopseudotumor
Emery et al.
Arch Neurol 1986;43:757-757.
ABSTRACT  

Permanent Visual Impairment in Childhood Pseudotumor Cerebri
Lessell and Rosman
Arch Neurol 1986;43:801-804.
ABSTRACT  

Observations on the Management of Pseudotumor Cerebri
McGreal
Arch Neurol 1986;43:168-168.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.